The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.
BARD1
BRCA1
Cancer
DNA repair
Genome integrity
Journal
Pharmacology & therapeutics
ISSN: 1879-016X
Titre abrégé: Pharmacol Ther
Pays: England
ID NLM: 7905840
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
14
08
2021
revised:
22
08
2021
accepted:
20
09
2021
pubmed:
8
10
2021
medline:
1
4
2022
entrez:
7
10
2021
Statut:
ppublish
Résumé
The breast cancer type 1 susceptibility protein (BRCA1) and its partner - the BRCA1-associated RING domain protein 1 (BARD1) - are key players in a plethora of fundamental biological functions including, among others, DNA repair, replication fork protection, cell cycle progression, telomere maintenance, chromatin remodeling, apoptosis and tumor suppression. However, mutations in their encoding genes transform them into dangerous threats, and substantially increase the risk of developing cancer and other malignancies during the lifetime of the affected individuals. Understanding how BRCA1 and BARD1 perform their biological activities therefore not only provides a powerful mean to prevent such fatal occurrences but can also pave the way to the development of new targeted therapeutics. Thus, through this review work we aim at presenting the major efforts focused on the functional characterization and structural insights of BRCA1 and BARD1, per se and in combination with all their principal mediators and regulators, and on the multifaceted roles these proteins play in the maintenance of human genome integrity.
Identifiants
pubmed: 34619284
pii: S0163-7258(21)00211-4
doi: 10.1016/j.pharmthera.2021.108009
pii:
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
Tumor Suppressor Proteins
0
BARD1 protein, human
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
108009Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there are no conflicts of interest.